Abstract
Glaucoma is one of the leading causes of irreversible blindness worldwide, affecting millions and placing a significant burden on healthcare systems. Despite advances in intraocular pressure (IOP) control, glaucomatous neuropathy (GN) can progress even at normal IOP levels, particularly in normal-tension glaucoma (NTG). Emerging evidence indicates that oxidative stress, neuroinflammation,…